XWELL Expands Beyond Airports with New Wellness Retail Location in New York City's Pennsylvania Station Bringing Accessible Self-Care to One of the Nation's Busiest Commuter Hubs GlobeNewswire December 18, 2025 NEW YORK, Dec. 18, 2025 (GLOBE NEWSWIRE) — XWELL (Nasdaq: XWEL) (“XWELL” or the “Company”), a leading provider of wellness solutions for people on the […]

SUO-CTC and CG Oncology Announce the Second Annual Non-Muscle Invasive Bladder Cancer (NMIBC) Research Fellowship Award GlobeNewswire December 18, 2025 Two applicants will each receive a Grant of $50,000 to support the development of outstanding clinical cancer research to improve the treatment of NMIBC Applications for the fellowship are due on February 27, 2026 SCHAUMBURG,

Larimar Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference GlobeNewswire December 18, 2025 BALA CYNWYD, Pa., Dec. 18, 2025 (GLOBE NEWSWIRE) — Larimar Therapeutics, Inc. (Larimar) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today announced that members of the company's management team will present and

RESTEM to Participate in the 15th LifeSci Partners Corporate Access Event Held During the J.P. Morgan Healthcare Conference in January 2026 GlobeNewswire December 18, 2025 MIAMI, Dec. 18, 2025 (GLOBE NEWSWIRE) — RESTEM – a clinical-stage biotechnology company that develops off-the-shelf, next-generation cell therapies designed to modulate the immune system, today announced its management team

HBT Financial, Inc. Announces Authorization of New $30 Million Stock Repurchase Program GlobeNewswire December 18, 2025 BLOOMINGTON, Ill., Dec. 18, 2025 (GLOBE NEWSWIRE) — HBT Financial, Inc. (NASDAQ: HBT) (the “Company” or “HBT Financial”) announced today that its Board of Directors has approved a new stock repurchase program (the “Program”) that takes effect upon the

Pacira Biosciences Joins PROBE Consortium to Transform Osteoarthritis Research and Care GlobeNewswire December 18, 2025 –Public-private partnership aims to improve osteoarthritis research, diagnosis and treatment––PROBE will leverage data from over 70 million individuals across multiple OA cohorts and real-world registries– BRISBANE, Calif., Dec. 18, 2025 (GLOBE NEWSWIRE) — Pacira Biosciences, Inc. (NASDAQ: PCRX), the industry

Icon Energy Corp. Announces Share Repurchase Program GlobeNewswire December 18, 2025 ATHENS, Greece, Dec. 18, 2025 (GLOBE NEWSWIRE) — Icon Energy Corp. (“Icon” or the “Company“) (Nasdaq: ICON), an international shipping company providing worldwide seaborne transportation services for dry bulk cargoes via its fleet of oceangoing vessels, announced today that its Board of Directors has

First Patient Dosed in SAB BIO's SAFEGUARD Clinical Trial of SAB-142 for the Treatment of Stage 3 T1D GlobeNewswire December 18, 2025 Enrollment in the SAFEGUARD trial is ongoing at multiple centers globally Company on-track to share Phase 2b data in 2H 2027 MIAMI, Dec. 18, 2025 (GLOBE NEWSWIRE) — SAB Biotherapeutics, Inc. (Nasdaq: SABS),

FCX INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Freeport McMoRan Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit GlobeNewswire December 18, 2025 SAN DIEGO, Dec. 18, 2025 (GLOBE NEWSWIRE) — Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Freeport-McMoRan Inc. (NYSE: FCX) publicly

Custom Ink Selects Innovative Partnerships Group to Drive Growth in Sports, Entertainment, and University Industries GlobeNewswire December 18, 2025 LOS ANGELES, Dec. 18, 2025 (GLOBE NEWSWIRE) — Custom Ink, the online leader in custom products and apparel for organizations, groups, and businesses announced today that it has selected Innovative Partnerships Group as its agency to